search icon
crvo-img

CervoMed Inc., Common Stock

CRVO

NAQ

$7.22

-$0.57

(-7.32%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$73.71M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
162.53K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$1.8 L
$22.57 H
$7.22

About CervoMed Inc., Common Stock

CervoMed Inc., a a clinical-stage biotechnology company, engages in the development and commercialization of treatments for age-related neurologic disorders. The company is developing neflamapimod, an orally administered small molecule brain penetrant that inhibits p38 mitogen-activated protein kinase alpha. Neflamapimod has the potential to treat synaptic dysfunction, the reversible aspect of the underlying neurodegenerative processes that cause disease in DLB and certain other major neurological disorders. It is being evaluated in a Phase 2b study in patients with DLB. The company develops EIP200 for central nervous system which is in preclinical trials. CervoMed Inc. was founded in 2010 and is headquartered in Boston, Massachusetts. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameCRVOSectorS&P500
1-Week Return-14.76%2.19%1.86%
1-Month Return-20.31%-5.18%6.39%
3-Month Return222.32%-10.56%-0.73%
6-Month Return-31.17%-9.48%-2.29%
1-Year Return-63.33%-5.95%12.88%
3-Year Return-41.37%0.73%42.84%
5-Year Return-92.24%30.6%93.02%
10-Year Return-99.97%77.03%179.63%

Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue---7.14M9.74M[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":73.37,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Cost of Revenue103.17K93.42K1.34M8.44M-[{"date":"2020-12-31","value":1.22,"profit":true},{"date":"2021-12-31","value":1.11,"profit":true},{"date":"2022-12-31","value":15.84,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Gross Profit(103.17K)(93.42K)(1.34M)(1.29M)9.74M[{"date":"2020-12-31","value":-1.06,"profit":false},{"date":"2021-12-31","value":-0.96,"profit":false},{"date":"2022-12-31","value":-13.72,"profit":false},{"date":"2023-12-31","value":-13.28,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Gross Margin---(18.11%)100.00%[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":-18.11,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Operating Expenses15.87M15.94M15.97M14.96M27.97M[{"date":"2020-12-31","value":56.76,"profit":true},{"date":"2021-12-31","value":57.02,"profit":true},{"date":"2022-12-31","value":57.11,"profit":true},{"date":"2023-12-31","value":53.49,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income(15.97M)(16.04M)(15.97M)(7.81M)(18.23M)[{"date":"2020-12-31","value":-1597494000,"profit":false},{"date":"2021-12-31","value":-1603811000,"profit":false},{"date":"2022-12-31","value":-1597218000,"profit":false},{"date":"2023-12-31","value":-781289500,"profit":false},{"date":"2024-12-31","value":-1822713100,"profit":false}]
Total Non-Operating Income/Expense228.51K(8.36M)(2.01M)5.86M3.87M[{"date":"2020-12-31","value":3.9,"profit":true},{"date":"2021-12-31","value":-142.72,"profit":false},{"date":"2022-12-31","value":-34.27,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":66.1,"profit":true}]
Pre-Tax Income(15.86M)(24.54M)(15.59M)(2.17M)(16.29M)[{"date":"2020-12-31","value":-1586068700,"profit":false},{"date":"2021-12-31","value":-2453962000,"profit":false},{"date":"2022-12-31","value":-1559142800,"profit":false},{"date":"2023-12-31","value":-217187300,"profit":false},{"date":"2024-12-31","value":-1629069500,"profit":false}]
Income Taxes(1.68M)(443.89K)(3.48M)800.00K-[{"date":"2020-12-31","value":-209.42,"profit":false},{"date":"2021-12-31","value":-55.49,"profit":false},{"date":"2022-12-31","value":-434.44,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes(14.19M)(24.10M)(12.12M)(2.97M)-[{"date":"2020-12-31","value":-1418530600,"profit":false},{"date":"2021-12-31","value":-2409572700,"profit":false},{"date":"2022-12-31","value":-1211589400,"profit":false},{"date":"2023-12-31","value":-297187800,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
Income From Continuous Operations(14.19M)(24.10M)(15.59M)(2.17M)(16.29M)[{"date":"2020-12-31","value":-1418530600,"profit":false},{"date":"2021-12-31","value":-2409572700,"profit":false},{"date":"2022-12-31","value":-1559142800,"profit":false},{"date":"2023-12-31","value":-217187300,"profit":false},{"date":"2024-12-31","value":-1629069500,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(14.19M)(24.10M)(15.59M)(2.17M)(16.29M)[{"date":"2020-12-31","value":-1418530600,"profit":false},{"date":"2021-12-31","value":-2409572700,"profit":false},{"date":"2022-12-31","value":-1559142800,"profit":false},{"date":"2023-12-31","value":-217187300,"profit":false},{"date":"2024-12-31","value":-1629069500,"profit":false}]
EPS (Diluted)(22.50)(18.75)(10.48)(4.64)(2.03)[{"date":"2020-12-31","value":-2250,"profit":false},{"date":"2021-12-31","value":-1875,"profit":false},{"date":"2022-12-31","value":-1048,"profit":false},{"date":"2023-12-31","value":-464.37,"profit":false},{"date":"2024-12-31","value":-202.62,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

CRVO
Cash Ratio 18.94
Current Ratio 20.73

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

CRVO
ROA (LTM) -56.19%
ROE (LTM) -93.42%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

CRVO
Debt Ratio Lower is generally better. Negative is bad. 0.10
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.90

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

CRVO
Trailing PE NM
Forward PE NM
P/S (TTM) 6.75
P/B 1.81
Price/FCF NM
EV/R 0.00
EV/Ebitda 1.64

FAQs

What is CervoMed Inc. share price today?

CervoMed Inc. (CRVO) share price today is $7.22

Can Indians buy CervoMed Inc. shares?

Yes, Indians can buy shares of CervoMed Inc. (CRVO) on Vested. To buy CervoMed Inc. from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in CRVO stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of CervoMed Inc. be purchased?

Yes, you can purchase fractional shares of CervoMed Inc. (CRVO) via the Vested app. You can start investing in CervoMed Inc. (CRVO) with a minimum investment of $1.

How to invest in CervoMed Inc. shares from India?

You can invest in shares of CervoMed Inc. (CRVO) via Vested in three simple steps:

  • Click on Sign Up or Invest in CRVO stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in CervoMed Inc. shares
What is CervoMed Inc. 52-week high and low stock price?

The 52-week high price of CervoMed Inc. (CRVO) is $22.57. The 52-week low price of CervoMed Inc. (CRVO) is $1.8.

What is CervoMed Inc. price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of CervoMed Inc. (CRVO) is 1.81

What is the Market Cap of CervoMed Inc.?

The market capitalization of CervoMed Inc. (CRVO) is $73.71M

What is CervoMed Inc.’s stock symbol?

The stock symbol (or ticker) of CervoMed Inc. is CRVO

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top